These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis. Wallace RJ, Nash DR, Steingrube VA. Am J Med; 1990 May 14; 88(5A):46S-50S. PubMed ID: 2111092 [Abstract] [Full Text] [Related]
3. Branhamella catarrhalis: beta-lactamase production and sensitivity to oral antibiotics, including new cephalosporins. Stobberingh EE, Wunderink M, Philips M, Houben A. J Antimicrob Chemother; 1987 Nov 14; 20(5):765-6. PubMed ID: 3123451 [No Abstract] [Full Text] [Related]
6. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998. Mikucka A, Janicka G, Krawiecka D, Kochanowska J. Med Sci Monit; 2000 Nov 14; 6(2):300-4. PubMed ID: 11208326 [Abstract] [Full Text] [Related]
7. [Susceptibility of Branhamella catarrhalis to antibiotics]. Leszczyńska K, Jakoniuk P, Sacha PT, Zalewska M, Wieczorek P. Med Dosw Mikrobiol; 2004 Nov 14; 56(3):231-7. PubMed ID: 15773499 [Abstract] [Full Text] [Related]
8. The frequency of BRO β-lactamase and its relationship to antimicrobial susceptibility and serum resistance in Moraxella catarrhalis. Saito R, Nonaka S, Fujinami Y, Matsuoka S, Nakajima S, Nishiyama H, Okamura N. J Infect Chemother; 2014 Jan 14; 20(1):6-8. PubMed ID: 24462416 [Abstract] [Full Text] [Related]
9. In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalis. Fernández-Roblas R, Jiménez Arriero M, Rodriguez-Tudela JL, Soriano F. J Antimicrob Chemother; 1988 Dec 14; 22(6):867-72. PubMed ID: 3149634 [Abstract] [Full Text] [Related]
11. A note on susceptibility of Branhamella catarrhalis to heavy metals. Riley TV, Taylor ML. J Appl Bacteriol; 1989 Aug 14; 67(2):185-9. PubMed ID: 2509410 [Abstract] [Full Text] [Related]
13. [Antimicrobial activity of cefetamet against fresh clinical isolates of Branhamella catarrhalis]. Deguchi K, Yokota N, Koguchi M, Nakane Y, Suzuki Y, Fukayama S, Ishihara R, Oda S. Jpn J Antibiot; 1992 Apr 14; 45(4):359-63. PubMed ID: 1518118 [Abstract] [Full Text] [Related]
14. Amoxicillin/clavulanate therapy of respiratory tract infections: a microbiologic perspective. Cunha BA. Clin Ther; 1992 Apr 14; 14(3):418-25. PubMed ID: 1638583 [Abstract] [Full Text] [Related]
15. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics]. Texier-Maugein J, Escoubas J, Fouche J, Mormede M. Pathol Biol (Paris); 1988 May 14; 36(5):540-3. PubMed ID: 3136431 [Abstract] [Full Text] [Related]
16. Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan. Lau YJ, Hsueh PR, Liu YC, Shyr JM, Huang WK, Teng LJ, Liu CY, Luh KT. Microb Drug Resist; 2006 May 14; 12(2):130-5. PubMed ID: 16922631 [Abstract] [Full Text] [Related]
17. beta-Lactam resistance and beta-lactamase isoforms of Moraxella catarrhalis isolates in Taiwan. Fung CP, Lee SC, Liu PY, Jang TN, Wong FD, Kuo BI, Liu CY, Liu YC. J Formos Med Assoc; 1998 Jul 14; 97(7):453-7. PubMed ID: 9700241 [Abstract] [Full Text] [Related]
19. Antibiotic resistance. Epidemiology of resistance--respiratory tract infections. Thomson CJ. J Med Microbiol; 1997 Jun 14; 46(6):442-5. PubMed ID: 9379469 [No Abstract] [Full Text] [Related]
20. Antimicrobial susceptibility and beta-lactamase production of Moraxella catarrhalis isolates in Taiwan. Fung CP, Jang TN, Liu CY, Lau YJ, Liu YC, Chuang YC, Lee N. J Formos Med Assoc; 1995 Sep 14; 94(9):548-54. PubMed ID: 8696169 [Abstract] [Full Text] [Related] Page: [Next] [New Search]